Irritability in Huntington's disease

Psychiatry Research

Volumn 200, Issue 2-3, 2012, Pages 813-818

  Reedeker, Nanda ^a   Bouwens, Jos A ^a   Giltay, Erik J ^a   Le Mair, Sybrenne E ^a   Roos, Raymund A C ^a   van der Mast, Rose C ^a   van Duijn, Erik ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Centre for Mental Health Care Delfland   (Netherlands)

Author keywords

Huntington's disease; Irritability; Irritability Scale; Problem behaviours assessment; Psychometrics

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CAG REPEAT; CORRELATION ANALYSIS; DISEASE DURATION; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; HUNTINGTON CHOREA; IRRITABILITY; IRRITABILITY SCALE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RECEIVER OPERATING CHARACTERISTIC; UNIVARIATE ANALYSIS;

ADULT; AGED; FEMALE; HUMANS; HUNTINGTON DISEASE; IRRITABLE MOOD; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; SELF REPORT;

EID: 84872395053     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2012.03.041     Document Type: Article

References (30)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, 4th ed.
2. Bond A.J., Curran H.V., Bruce M.S., O'Sullivan G., Shine P. Behavioural aggression in panic disorder after 8 weeks' treatment with alprazolam. Journal of Affective Disorders 1995, 35:117-123.
3. Chatterjee A., Anderson K.E., Moskowitz C.B., Hauser W.A., Marder K.S. A comparison of self-report and caregiver assessment of depression, apathy, and irritability in Huntington's disease. Journal of Neuropsychiatry and Clinical Neurosciences 2005, 17:378-383.
4. Craig K.J., Hietanen H., Markova I.S., Berrios G. The Irritability Questionnaire: a new scale for the measurement of irritability. Psychiatry Research 2008, 159:367-375.
5. Craufurd D., Thompson J.C., Snowden J.S. Behavioral changes in Huntington disease. Neuropsychiatry Neuropsychology Behavioral Neurology 2001, 14:219-226.
6. Duff K., Paulsen J.S., Beglinger L.J., Langbehn D.R., Stout J.C. Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study. Biological Psychiatry 2007, 62:1341-1346. the Predict-HD Investigators of the Huntington Study Group.
7. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. Journal Psychiatric Research 1975, 12:189-198.
8. Hodges J.R. Cognitive Assessment for Clinicians 2009, Oxford University Press, Oxford. 2nd ed.
9. Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983.
10. Huntington Study Group Unified Huntington's Disease Rating Scale: reliability and consistency. Movement Disorders 1996, 11:136-142.
11. Kingma E.M., van Duijn E., Timman R., van der Mast R.C., Roos R.A.C. Behavioural problems in Huntington's disease using the Problem Behaviours Assessment. General Hospital Psychiatry 2008, 30:155-161.
12. Klöppel S., Stonnington C.M., Petrovic P., Mobbs D., Tüscher O., Craufurd D., Tabrizi S.J., Frackowiak R.S.J. Irritability in pre-clinical Huntington's disease. Neuropsychologia 2010, 48:549-557.
13. Kulisevsky J., Litvan I., Berthier M.L., Pascual-Sedano B., Paulsen J.S., Cummings J.L. Neuropsychiatric assessment of Gilles de la Tourette patients: comparative study with other hyperkinetic and hypokinetic movement disorders. Movement Disorders 2010, 16:1098-1104.
14. Lader M., Morton S. Benzodiazepine problems. British Journal of Addiction 1991, 86:823-828.
15. Murgod U.A., Saleem Q., Anand A., Brahmachari S.K., Jain S., Muthane U.B. A clinical study of patients with genetically confirmed Huntington's disease from India. Journal of the Neurological Sciences 2001, 190:73-78.
16. Paulsen J.S., Ready R.E., Hamilton J.M., Mega M.S., Cummings J.L. Neuropsychiatric aspects of Huntington's disease. Journal of Neurology, Neurosurgery, and Psychiatry 2001, 71:310-314.
17. Ravina B., Romer M., Constantinescu R., Biglan K., Brocht A., Kieburtz K., Shoulson I., McDermott M.P. The relationship between CAG repeat length and clinical progression in Huntington's disease. Movement Disorders 2008, 23:1223-1227.
18. Robins L.N., Wing J., Wittchen H.-U., Helzer J.E., Babor T.F., Burke J., Farmer A., Jablensky A., Pickens R., Regier D.A., Sartorius N., Towle L.H. The Composite International Diagnostic Interview: an epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Archives of General Psychiatry 1989, 45:1069-1077.
19. Shoulson I., Fahn S. Huntington disease: clinical care and evaluation. Neurology 1979, 29:1-3.
20. Smith A. The Symbol Digit Modalities Test: a neuropsychologic test for economic screening of learning and other cerebral disorders. Learning Disorders 1968, 3:83-91.
21. Snaith R.P., Taylor C.M. Irritability: definition, assessment and associated factors. British Journal of Psychiatry 1985, 147:127-136.
22. Stroop J.R. Studies of interference in serial verbal reactions. Journal of Experimental Psychology 1935, 18:643-662.
23. van Duijn E., Kingma E.M., van der Mast R.C. Psychopathology in verified Huntington's disease gene carriers. Journal of Neuropsychiatry and Clinical Neurosciences 2007, 19:441-448.
24. van Duijn E. Treatment of irritability in Huntington's disease. Current Treatment Options in Neurology 2010, 12:424-433.
25. Vassos E., Panas M., Kladi A., Vassilopoulos D. Higher levels of extroverted hostility detected in gene carriers at risk for Huntington's disease. Biological Psychiatry 2007, 62:1347-1352.
26. Vassos E., Panas M., Kladi A., Vassilopoulos D. Effect of CAG repeat length on psychiatric disorders in Huntington's disease. Journal of Psychiatric Research 2008, 42:544-549.
27. Walker F.O. Huntington's disease. Lancet 2007, 369:218-223.
28. Weigell-Weber M., Schmid W., Spiegel R. Psychiatric symptoms and CAG expansion in Huntington's disease. American Journal of Medical Genetics 1996, 67:53-57.
29. Weisman A.M., Berman M.E., Taylor S.P. Effects of clorazepate, diazepam, and oxazepam on a laboratory measurement of aggression in men. International Clinical Psychopharmacology 1998, 13:183-188.
30. Zappacosta B., Monza D., Meoni C., Austoni L., Soliveri P., Gellera C., Alberti R., Mantero M., Penati G., Caraceni T., Girotti F. Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease. Archives of Neurology 1996, 53:493-497.